Type 2 diabetes: risk displayed in early pregnancy blood samples

As gestational diabetes is a well-known risk factor for type 2 diabetes, researchers wanted to study whether it would be possible to identify the women who have an increased risk of type 2 diabetes already based on their metabolism during pregnancy.

Mothers’ risk of type 2 diabetes was examined at the mother-child study conducted at the University of Turku and Turku University Hospital in Finland. The metabolic profiles of the mothers’ blood samples, in other words their serum metabolic profiles, in early and late pregnancy were measured with a method that recognises over 200 metabolites and their ratios. In addition, the mothers’ fasting blood glucose and insulin resistance were evaluated with traditional laboratory tests at postpartum. The serum metabolic profiles during pregnancy were compared for women who developed prediabetes and women whose fasting glucose remained at a regular level at two years postpartum.

“We discovered that the metabolic profile in early pregnancy together with clinical variables, such as age and pre-pregnancy body mass index, predicted prediabetes at postpartum. Higher concentrations of small HDL particles in blood circulation during early pregnancy were associated with higher fasting glucose and insulin resistance at two years postpartum,” says Doctoral Researcher Ella Muhli from the Early Nutrition and Health research group of the University of Turku.

“Based on our findings, women at increased risk for type 2 diabetes could possibly be identified in early pregnancy based on their serum metabolic profiles. However, similar associations were not detected in late pregnancy,” adds Muhli.

The higher concentration of the small HDL particles in circulation has been previously associated with the risk of cardiovascular diseases, in addition to the risk for type 2 diabetes.

MEDICA-tradefair.com; Source: University of Turku